LAZARD ASSET MANAGEMENT LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$112
-99.8%
7,5420.0%0.00%
Q3 2022$62,000
+26.5%
7,5420.0%0.00%
Q2 2022$49,000
+16.7%
7,5420.0%0.00%
Q1 2022$42,000
+20.0%
7,5420.0%0.00%
Q4 2021$35,0007,5420.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
PATHWAY CAPITAL MANAGEMENT, LP 245,606$3,671,8106.55%
AIGH Capital Management LLC 695,358$10,395,6023.42%
BARDIN HILL MANAGEMENT PARTNERS LP 638,360$9,5442.08%
Kellner Capital, LLC 100,016$1,4951.74%
NEXPOINT ASSET MANAGEMENT, L.P. 1,464,807$21,898,8651.70%
Worth Venture Partners, LLC 170,925$2,555,3291.51%
Birchview Capital, LP 100,000$1,4951.06%
BCK CAPITAL MANAGEMENT LP 68,000$1,016,6001.05%
WATER ISLAND CAPITAL LLC 698,915$10,4490.89%
EHP Funds Inc. 292,043$4,3660.82%
View complete list of AVEO PHARMACEUTICALS INC shareholders